Aminoacyl-CoAs as probes of condensation domain selectivity in nonribosomal peptide synthesis

Science

Volumn 284, Issue 5413, 1999, Pages 486-489

  Belshaw, Peter J ^a   Walsh, Christopher T ^a   Stachelhaus, Torsten ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; CARRIER PROTEIN;

ADENYLATION; AMINO ACID ANALYSIS; ARTICLE; ENZYME ANALYSIS; ENZYME SPECIFICITY; ENZYME STABILITY; PEPTIDE SYNTHESIS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING;

ACYL CARRIER PROTEIN; ACYL COENZYME A; AMINO ACID ISOMERASES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DIPEPTIDES; MASS SPECTROMETRY; PANTETHEINE; PEPTIDE BIOSYNTHESIS; PEPTIDE SYNTHASES; PHENYLALANINE; PROLINE; RIBOSOMES;

EID: 0033574774     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.284.5413.486     Document Type: Article

References (30)

1. M. A. Marahiel, T. Stachelhaus, H. D. Mootz, Chem. Rev. 97, 2651 (1997); D. E. Cane, C. T. Walsh, C. Khosla, Science 282, 63 (1998); H. Kleinkauf and H. von Döhren. Eur. J. Biochem. 236, 335 (1996).
2. M. A. Marahiel, T. Stachelhaus, H. D. Mootz, Chem. Rev. 97, 2651 (1997); D. E. Cane, C. T. Walsh, C. Khosla, Science 282, 63 (1998); H. Kleinkauf and H. von Döhren. Eur. J. Biochem. 236, 335 (1996).
3. M. A. Marahiel, T. Stachelhaus, H. D. Mootz, Chem. Rev. 97, 2651 (1997); D. E. Cane, C. T. Walsh, C. Khosla, Science 282, 63 (1998); H. Kleinkauf and H. von Döhren. Eur. J. Biochem. 236, 335 (1996).
4. NRPSs also direct the synthesis of virulence-conferring siderophore peptides, exochelin [W. M. Zhu, et al., Mol. Microbiol. 29, 629 (1998)], yersiniabactin [A. M. Gehring et al., Chem. Biol. 5, 573 (1998)], and pyochelin from pathogenic mycobacteria, yersinia, and pseudomonads, respectively, as well as the hepatotoxic microcystins (E. Dittmann et al., Mol. Microbiol. 26, 779 (1997)] that are potent phosphoprotein phosphatase inhibitors.
5. NRPSs also direct the synthesis of virulence-conferring siderophore peptides, exochelin [W. M. Zhu, et al., Mol. Microbiol. 29, 629 (1998)], yersiniabactin [A. M. Gehring et al., Chem. Biol. 5, 573 (1998)], and pyochelin from pathogenic mycobacteria, yersinia, and pseudomonads, respectively, as well as the hepatotoxic microcystins (E. Dittmann et al., Mol. Microbiol. 26, 779 (1997)] that are potent phosphoprotein phosphatase inhibitors.
6. NRPSs also direct the synthesis of virulence-conferring siderophore peptides, exochelin [W. M. Zhu, et al., Mol. Microbiol. 29, 629 (1998)], yersiniabactin [A. M. Gehring et al., Chem. Biol. 5, 573 (1998)], and pyochelin from pathogenic mycobacteria, yersinia, and pseudomonads, respectively, as well as the hepatotoxic microcystins (E. Dittmann et al., Mol. Microbiol. 26, 779 (1997)] that are potent phosphoprotein phosphatase inhibitors.
7. R. H. Lambalot et al., Chem. Biol. 3, 923 (1996).
8. T. Stachelhaus, A. Schneider, M. A. Marahiel, Science 269, 69 (1995); A. Schneider, T. Stachelhaus, M. A. Marahiel, Mol. Gen. Genet. 257, 308 (1998).
9. T. Stachelhaus, A. Schneider, M. A. Marahiel, Science 269, 69 (1995); A. Schneider, T. Stachelhaus, M. A. Marahiel, Mol. Gen. Genet. 257, 308 (1998).
10. E. Conti et al., EMBO J. 16, 4174 (1997).
11. K. Hori et al., J. Biochem. 106, 639 (1989); K. Turgay et al., Mol. Microbiol. 6, 529 (1992).
12. K. Hori et al., J. Biochem. 106, 639 (1989); K. Turgay et al., Mol. Microbiol. 6, 529 (1992).
13. H. Kleinkauf and H. von Döhren, in Advances in Biotechnology, M. Moo-Young, Ed. (Pergamon, London, 1981), vol. 3, pp. 83-88.
14. J. Coste et al., Tetrahedron Lett. 31, 205 (1990).
15. 4 over 25 min, 10 ml/min, monitor at 280 nm), and desalted. After removal of methanol on a rotary evaporator, the sample was lyophilized to give the aa-S-CoA (50 to 80% yield) as a white solid.
16. L E. N. Quadri et al., Biochemistry 37, 1585 (1998).
17. PheATE, PheAT, PheTE, and PheT are deletion mutants or derivatives of the phenylalanine (Phe)-activating enzyme GrsA, containing combinations of the A domain, the T domain, and the epimerization (E) domain. ProCAT is the recombinant first module of TycB, containing a proline (Pro)-activating A domain, a T domain, and the upstream C domain.
18. 3H]Phe-transfer assay. His-tagged and untagged PheATE are enzymatically identical.
19. -1). Nvoc-D-Ala-S-CoA (P, 20:27:0.7), Nvoc-L-Ala-S-CoA (P, 18:20:0.9), Nvoc-D-Phe-S-CoA (P, 18:13:1.4) and (A, 16:9:1.8). D-Phe-S-CoA (P, 15:8:1.9), Nvoc-L-Phe-S-CoA (P, 17:17:1), L-Phe-S-CoA (P, 22:19:1.2). For PheAT acceptor: Nvoc-D-Phe-S-CoA (A, 17:16:1.1). For PheTE acceptor: Nvoc-D-Phe-S-CoA (A, 15:16:0.9).
20. P. Belshaw, C. Walsh, T. Stachelhaus, data not shown.
21. T. Stachelhaus, H. D. Mootz, V. Bergendahl, M. A. Marahiel, J. Biol. Chem. 273, 22773 (1998).
22. 3H]Pro (24.7 Ci/mmol). Simultaneously, a 1 μM solution of the other aminoacylated, module in MES buffer, pH 8.0, was also incubated at 37°C After 3 min, the condensation reaction was initiated by combining equal volumes of both solutions. At various time points, 100-μl samples were taken and immediately quenched by the addition of 0.8 ml of 10% trichloroacetic acid (TCA) (w/v) and 20 μl of bovine serum albumin (BSA) solution [2% (w/v)]. The TCA precipitate was washed once with 0.5 ml of 10% TCA (w/v), and the acid-stable label was quantified by LSC. The supernatants were extracted with 0.5 ml of butanol/chloroform [4:1; (v/v)], the organic layers were washed once with 0.5 ml of 0.1 M NaCl, and the amount of extractable label (DKP) was quantified by LSC (15).
23. -1.
24. V. de Crécy-Lagard, P. Marliere, W. Saurin, C. R. Acad. Sci. Ser. III Sci. Vie 318, 927 (1995).
25. V. de Crécy-Lagard et al., J. Bacteriol. 179, 705 (1997).
26. T. Stein et al., J. Biol. Chem. 271, 15428 (1996); J. Vater, et al., J. Prot. Chem. 16, 557 (1997).
27. T. Stein et al., J. Biol. Chem. 271, 15428 (1996); J. Vater, et al., J. Prot. Chem. 16, 557 (1997).
28. H. Jakubowski, Biochemistry 37, 5147 (1998).
29. U. Keller, J. Biol. Chem. 262, 5852 (1987).
30. Supported in part by NIH grant GM20011, an European Molecular Biology Organization fellowship (T.S.) and a fellowship from the Jane Coffin Childs Memorial Fund for Medical Research (P.J.B.).